Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

2.

[Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].

Akagawa Y, Ueno A, Ikeda J, Ishii W, Shishido-Hara Y, Sekijima Y.

Rinsho Shinkeigaku. 2018 May 25;58(5):324-331. doi: 10.5692/clinicalneurol.cn-001166. Epub 2018 Apr 28. Japanese.

PMID:
29710027
3.

A Punctate Magnetic Resonance Imaging Pattern in a Patient with Systemic Lupus Erythematosus is an Early Sign of Progressive Multifocal Leukoencephalopathy: A Clinicopathological Study.

Ishii J, Shishido-Hara Y, Kawamoto M, Fujiwara S, Imai Y, Nakamichi K, Kohara N.

Intern Med. 2018 Apr 27. doi: 10.2169/internalmedicine.0696-17. [Epub ahead of print]

4.

Pathologic Findings and Clinical Course of Midline Paraventricular Gliomas Diagnosed Using a Neuroendoscope.

Fukami S, Nakajima N, Okada H, Akimoto J, Miki T, Fukuhara H, Shishido-Hara Y, Nagao T, Tsuda M, Kohno M.

World Neurosurg. 2018 Jun;114:e366-e377. doi: 10.1016/j.wneu.2018.02.185. Epub 2018 Mar 9.

PMID:
29530692
5.

Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy.

Lee J, Shishido-Hara Y, Suzuki K, Shimizu S, Kobayashi K, Kamma H, Shiokawa Y, Nagane M.

Jpn J Clin Oncol. 2017 Oct 1;47(10):925-934. doi: 10.1093/jjco/hyx098.

PMID:
28981733
6.

Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment.

Sanjo N, Kina S, Shishido-Hara Y, Nose Y, Ishibashi S, Fukuda T, Maehara T, Eishi Y, Mizusawa H, Yokota T.

Intern Med. 2016;55(12):1631-5. doi: 10.2169/internalmedicine.55.6051. Epub 2016 Jun 15.

7.

[Progressive Multifocal Leukoencephalopathy with Inflammatory Reactions].

Shishido-Hara Y, Uchihara T, Sanjo N.

Brain Nerve. 2016 Apr;68(4):479-88. doi: 10.11477/mf.1416200422. Japanese.

PMID:
27056866
8.

Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.

Nitta Y, Shimizu S, Shishido-Hara Y, Suzuki K, Shiokawa Y, Nagane M.

Cancer Med. 2016 Mar;5(3):486-99. doi: 10.1002/cam4.614. Epub 2016 Jan 18.

9.

PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells.

Ishii J, Yazawa T, Chiba T, Shishido-Hara Y, Arimasu Y, Sato H, Kamma H.

Endocrinology. 2016 Mar;157(3):1289-98. doi: 10.1210/en.2015-1973. Epub 2016 Jan 13.

PMID:
26760117
10.

Genomic characterization of primary central nervous system lymphoma.

Fukumura K, Kawazu M, Kojima S, Ueno T, Sai E, Soda M, Ueda H, Yasuda T, Yamaguchi H, Lee J, Shishido-Hara Y, Sasaki A, Shirahata M, Mishima K, Ichimura K, Mukasa A, Narita Y, Saito N, Aburatani H, Nishikawa R, Nagane M, Mano H.

Acta Neuropathol. 2016 Jun;131(6):865-75. doi: 10.1007/s00401-016-1536-2. Epub 2016 Jan 12.

PMID:
26757737
11.

Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.

Shishido-Hara Y.

Neuropathology. 2015 Oct;35(5):487-96. doi: 10.1111/neup.12203. Epub 2015 May 6. Review.

PMID:
25946231
12.

[What matters more in the white matter: thinking inside of the brain].

Uchihara T, Shishido-Hara Y.

Brain Nerve. 2015 Apr;67(4):371-87. doi: 10.11477/mf.1416200153. Review. Japanese.

PMID:
25846587
13.

Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.

Ishii J, Sato H, Yazawa T, Shishido-Hara Y, Hiramatsu C, Nakatani Y, Kamma H.

Pathol Int. 2014 Sep;64(9):415-22. doi: 10.1111/pin.12198.

PMID:
25243889
14.

Expression of developing neural transcription factors in lung carcinoid tumors.

Endo T, Yazawa T, Shishido-Hara Y, Fujiwara M, Shimoyamada H, Ishii J, Sato H, Tachibana K, Takei H, Kondo H, Goya T, Endo S, Kamma H.

Pathol Int. 2014 Aug;64(8):365-74. doi: 10.1111/pin.12183.

PMID:
25143124
15.

JC virus inclusions in progressive multifocal leukoencephalopathy: scaffolding promyelocytic leukemia nuclear bodies grow with cell cycle transition through an S-to-G2-like state in enlarging oligodendrocyte nuclei.

Shishido-Hara Y, Yazawa T, Nagane M, Higuchi K, Abe-Suzuki S, Kurata M, Kitagawa M, Kamma H, Uchihara T.

J Neuropathol Exp Neurol. 2014 May;73(5):442-53. doi: 10.1097/NEN.0000000000000066.

16.

Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast.

Tazaki E, Shishido-Hara Y, Mizutani N, Nomura S, Isaka H, Ito H, Imi K, Imoto S, Kamma H.

Pathol Int. 2013 Jun;63(6):297-304. doi: 10.1111/pin.12065.

17.

POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.

Ishii J, Sato H, Sakaeda M, Shishido-Hara Y, Hiramatsu C, Kamma H, Shimoyamada H, Fujiwara M, Endo T, Aoki I, Yazawa T.

Pathol Int. 2013 Mar;63(3):158-68. doi: 10.1111/pin.12042.

PMID:
23530560
18.

Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer.

Sakaeda M, Sato H, Ishii J, Miyata C, Kamma H, Shishido-Hara Y, Shimoyamada H, Fujiwara M, Endo T, Tanaka R, Kondo H, Goya T, Aoki I, Yazawa T.

Lab Invest. 2013 Apr;93(4):408-21. doi: 10.1038/labinvest.2013.2. Epub 2013 Jan 28.

19.

Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.

Nagane M, Kobayashi K, Tanaka M, Tsuchiya K, Shishido-Hara Y, Shimizu S, Shiokawa Y.

Int J Clin Oncol. 2014 Feb;19(1):16-23. doi: 10.1007/s10147-013-0517-x. Epub 2013 Jan 26.

PMID:
23354833
20.

[Progressive multifocal leukoencephalopathy (PML)].

Mizusawa H, Kishida S, Saijo M, Yukishita M, Shishido-Hara Y, Sawa H, Nagashima K, Nukuzuma S, Yamada M.

Rinsho Shinkeigaku. 2011 Nov;51(11):1051-7. Japanese.

PMID:
22277475
21.

JC virus intranuclear inclusions associated with PML-NBs: analysis by electron microscopy and structured illumination microscopy.

Shishido-Hara Y, Ichinose S, Uchihara T.

Am J Pathol. 2012 Mar;180(3):1095-106. doi: 10.1016/j.ajpath.2011.11.036. Epub 2012 Jan 21.

22.

Extremely enlarged right atrial appendage in paediatric idiopathic pulmonary hypertension.

Kurata A, Shishido-Hara Y, Hosaki A.

Acta Cardiol. 2010 Aug;65(4):483-5.

PMID:
20821946
23.

Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages?

Shishido-Hara Y, Kurata A, Fujiwara M, Itoh H, Imoto S, Kamma H.

Diagn Pathol. 2010 Aug 23;5:55. doi: 10.1186/1746-1596-5-55.

24.
25.

Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.

Hirano K, Shishido-Hara Y, Kitazawa A, Kojima K, Sumiishi A, Umino M, Kikuchi F, Sakamoto A, Fujioka Y, Kamma H.

Pathol Res Pract. 2008;204(11):799-807. doi: 10.1016/j.prp.2008.05.002. Epub 2008 Jul 3.

PMID:
18602222
26.

Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid.

Matsumoto H, Sakamoto A, Fujiwara M, Yano Y, Shishido-Hara Y, Fujioka Y, Kamma H.

Oncol Rep. 2008 Jun;19(6):1405-11.

PMID:
18497944
27.

Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.

Shishido-Hara Y, Higuchi K, Ohara S, Duyckaerts C, Hauw JJ, Uchihara T.

J Neuropathol Exp Neurol. 2008 Apr;67(4):299-308. doi: 10.1097/NEN.0b013e31816a1dd3.

PMID:
18379438
28.

Cyclic AMP-mediated growth suppression and MAPK phosphorylation in thyroid papillary carcinoma cells.

Matsumoto H, Sakamoto A, Fujiwara M, Yano Y, Shishido-Hara Y, Fujioka Y, Kamma H.

Mol Med Rep. 2008 Mar-Apr;1(2):245-9.

PMID:
21479404
30.
32.

JC virusType 2: definition of subtypes based on DNA sequence analysis of ten complete genomes.

Agostini HT, Shishido-Hara Y, Baumhefner RW, Singer EJ, Ryschkewitsch CF, Stoner GL.

J Gen Virol. 1998 May;79 ( Pt 5):1143-51.

PMID:
9603329

Supplemental Content

Loading ...
Support Center